Ventas (VTR) Reports Q3 Earnings: What Key Metrics Have to Say

Core Insights - Ventas reported $1.49 billion in revenue for the quarter ended September 2025, marking a year-over-year increase of 20.4% and exceeding the Zacks Consensus Estimate by 3.86% [1] - The earnings per share (EPS) for the same period was $0.88, a significant increase from $0.05 a year ago, surpassing the consensus EPS estimate of $0.87 by 1.15% [1] Revenue Breakdown - Resident fees and services generated $1.09 billion, exceeding the average estimate of $1.05 billion by analysts, reflecting a year-over-year change of 28.7% [4] - Interest and other income amounted to $4.18 million, compared to the estimated $2.83 million, but showed a decline of 49% year-over-year [4] - Rental income from outpatient medical & research portfolio was $226.2 million, slightly above the average estimate of $224.12 million, with a year-over-year increase of 2.4% [4] - Income from loans and investments reached $5.52 million, significantly higher than the average estimate of $4.35 million, representing a year-over-year increase of 193.7% [4] - Rental income totaled $386.25 million, surpassing the average estimate of $372.06 million, with a year-over-year change of 2.6% [4] - Third-party capital management revenues were $4.49 million, slightly above the average estimate of $4.41 million, reflecting a year-over-year increase of 2.3% [4] - Rental income from triple-net leased properties was $160.05 million, exceeding the average estimate of $149.42 million, with a year-over-year change of 3% [4] - Net earnings per share (diluted) were reported at $0.14, compared to the estimated $0.10 by analysts [4] Stock Performance - Over the past month, shares of Ventas have returned +0.1%, while the Zacks S&P 500 composite has changed by +3.8% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]